Abnormally Expressed lncRNAs as Potential Biomarkers for Gastric Cancer Risk: A Diagnostic Meta-Bioinformatics Analysis

Figure 2

SEN and SPE of lncRNA assay for diagnosis of GC. The pooled SEN: 0.71 (95% CI: 0.67-0.74); the pooled SPE: 0.76 (95% CI: 0.71-0.79).